Detalhe da pesquisa
1.
The immune system in Parkinson's disease: what we know so far.
Brain
; 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38833182
2.
Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder.
Proc Natl Acad Sci U S A
; 118(10)2021 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33658371
3.
Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson's disease and cognition.
Brain Behav Immun
; 101: 182-193, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35026420
4.
Size-Selective Phagocytic Clearance of Fibrillar α-Synuclein through Conformational Activation of Complement Receptor 4.
J Immunol
; 204(5): 1345-1361, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969389
5.
PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats.
Neurobiol Dis
; 149: 105229, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33352233
6.
Periphery and brain, innate and adaptive immunity in Parkinson's disease.
Acta Neuropathol
; 141(4): 527-545, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33555429
7.
Multiple system atrophy-associated oligodendroglial protein p25α stimulates formation of novel α-synuclein strain with enhanced neurodegenerative potential.
Acta Neuropathol
; 142(1): 87-115, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33978813
8.
Soluble CD163 Changes Indicate Monocyte Association With Cognitive Deficits in Parkinson's Disease.
Mov Disord
; 36(4): 963-976, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332647
9.
Immune system responses in Parkinson's disease: Early and dynamic.
Eur J Neurosci
; 49(3): 364-383, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30474172
10.
Alterations in Blood Monocyte Functions in Parkinson's Disease.
Mov Disord
; 34(11): 1711-1721, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31449711
11.
Betrayal of the Markers.
Cytometry A
; 103(9): 692-694, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37503651
12.
Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model.
J Neurosci
; 36(36): 9375-90, 2016 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27605613
13.
Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
Neurobiol Dis
; 106: 279-290, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28736195
14.
α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology.
J Neuroinflammation
; 13(1): 74, 2016 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27055651
15.
Amyloid-ß aggregates activate peripheral monocytes in mild cognitive impairment.
Nat Commun
; 15(1): 1224, 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38336934
16.
Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease.
Neurobiol Dis
; 56: 47-58, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23567651
17.
The systemic immune response in Parkinson's disease: focus on the peripheral immune component.
Trends Neurosci
; 46(10): 863-878, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37598092
18.
Sex-dimorphic neuroprotective effect of CD163 in an α-synuclein mouse model of Parkinson's disease.
NPJ Parkinsons Dis
; 9(1): 164, 2023 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38092806
19.
Enhanced production of mesencephalic dopaminergic neurons from lineage-restricted human undifferentiated stem cells.
Nat Commun
; 14(1): 7871, 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38052784
20.
GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
Brain
; 134(Pt 8): 2302-11, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21712347